Ross Walker
Follow
Get notifications in MyBN when activity occurs.
Ross Walker
Dr Ross Walker is an eminent practicing cardiologist with over 35 years’ experience as a clinician. For over 20 years, he has been focusing on preventative cardiology and is one of Australia’s leading preventative health experts.
Considered one of the world’s best keynote speakers and life coaches, he is the author of seven best-selling books, a health presenter in the Australian Media including regular appearances on the Nine Network’s ‘Today Show’ and ‘A Current Affair’, and Sky News, Switzer Business.
Mr Walker also has a weekly radio show on Sydney’s 2UE/ 4BC & 2CC with other regular segments on 2UE, 6PR, 4BC and 3AW.
Considered one of the world’s best keynote speakers and life coaches, he is the author of seven best-selling books, a health presenter in the Australian Media including regular appearances on the Nine Network’s ‘Today Show’ and ‘A Current Affair’, and Sky News, Switzer Business.
Mr Walker also has a weekly radio show on Sydney’s 2UE/ 4BC & 2CC with other regular segments on 2UE, 6PR, 4BC and 3AW.
Lists and Charts
Total Shareholder Return as at 29/02/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 91st | Botanix Pharmaceuticals | 100% | 43% |
| 335th | MGC Pharmaceuticals | 26% | -22% |
| 840th | HITIQ | -7% | |
| 1094th | rent.com.au | -25% | -13% |
| 1095th | Adisyn | -25% |
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 125th |  | MGC Pharmaceuticals | $4.2m |
| 132nd | | Botanix Pharmaceuticals | $3.8m |
| 135th |  | HITIQ | $3.2m |
| 137th |  | Adisyn | $2.9m |
| 138th | | rent.com.au | $2.8m |
201 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Person Activity
| NEWS: Tagged in Board Moves December 1, 2023 | 01 Dec 2023 |
| REMUNERATION UPDATE: Non-Executive Director, Head of Advisory Board, MGC Pharmaceuticals | 24 Aug 2020 |
| REMUNERATION UPDATE: Non-Executive Director, Head of Advisory Board, MGC Pharmaceuticals | 30 Jun 2020 |
News Articles
Related Information
Positions - Previous
| Position | Company | Year | Company's current rank |
|---|---|---|---|
| Non-Executive Director, Head of Advisory Board | | 2016 - 2023 | 125 |
| Director | | - | 64 |
Directors Interests
| Company | Date | Transaction type | Number of shares | Price per share | Transaction value | Nature of change |
|---|---|---|---|---|---|---|
| MGC Pharmaceuticals | 05 May 2023 | Other | 1,050,000 | OtherAs advised by the company: Lapse of Performance Rights | ||
| MGC Pharmaceuticals | 24 Nov 2021 | Other | 600,000 | OtherConversion of securities: 1,500,000 - Performance Rights | ||
| MGC Pharmaceuticals | 24 Nov 2021 | Bought | 600,000 | OtherConversion of securities | ||
| MGC Pharmaceuticals | 10 Jul 2020 | Issued | 185,185 | $0.00 | $741 | OtherParticipation in share purchase plan: Estimated valuation. |
| MGC Pharmaceuticals | 18 Mar 2020 | Bought | 370,370 | $0.03 | $10,000 | OtherParticipation in share purchase plan |
Powered by Morningstar ®
